Gambaran Darah Tepi pada Penderita Karsinoma Nasofaring Sebelum dan Sesudah Kemoradioterapi di RSUP.H.Adam Malik tahun 2015
36
DAFTAR PUSTAKA
1.
Indonesia KKR. Stop Kanker. Situasi Penyakit Kanker. 2015 Febuari: p. 7.
2.
Cao SM, Simons MJ, Qian aCN. The Prevalence and Prevention of
Nasopharyngeal Carcinoma in China. Chinese Journal of Cancer. 2011
january; 30(2).
3.
American Cancer Society. [Online].; 2015 [cited 2015 January 15. Available
from:
http://www.cancer.org/cancer/nasopharyngealcancer/detailedguide/nasophary
ngeal-cancer-what-is-nasopharyngeal-cancer
4.
International Agency of Research on Cancer. [Online].;2010 Available from:
http://www.iarc.fr/search.php?cx=009987501641899931167
5.
Richard S. Snell MD. Clinical Anatomy For Medical Students. 6th ed. et.al
HH, editor.: EGC; 2002.
6.
Nasional KPK. Panduan Praktisi Klinis Karsinoma Nasofaring: Kementrian
Kesehatan Republik Indonesia; 2008.
7.
Control UfIC. World Health Organization. [Online].; 2014 [cited 2016 April
23.
8.
Su O, Mao , Liang , Liu , al Je. American Cancer Society. [Online].; 2015
[cited 2016.
9.
Indonesia FKU. Buku Ajar Ilmu Kesehatan. In Prof.Dr.Efiaty Arsyad
Soepardi sTea, editor. Telinga Hidung Tenggorokan Kepala&Leher. Jakarta:
Fakultas Kedokteran Universitas Indonesia; 2007. p. 169.
10. Daniel T.T.Chua MBCB, Jonathan S.T.Sham MD, Damon T.k.Choy MBBS.
Prognostic Impact of Hemoglobin Levels on Treatment Outcome in Patients
with Nasopharyngeal Carcinoma Treated with Sequential Chemoradiotherapy
or Radiotherapy Alone. American Cancer Society. 2004 June; 101(2).
11. su Z, Mao YP, OuYang PY, Tang J, Lan Xw, Xie FY. Leucopenia and treatment
effiacy in advanced nasopharyngeal carcinoma. BioMedCentral Cancer. 2015.
Universitas Sumatera Utara
37
12. Mehta A, Hoffbrand V. At a Glance Hematologi. 2nd ed. Safitri A,
Astikawati R, editors.: copyright Erlangga; 2008.
13. Lichtman MAMD, Beutler EMD, Kipps TJMD,PD, et.al. Williams
Hematology. 7th ed. Abboud CN,MDea, editor.: The Mc.Graw-Hill
Companies; 2007.
14. Warren Levinson Md. Review of Medical Microbiology and Immunology.
9th ed. Malley J, Pancotti R, Davis K, editors. United Stage America: Mc
Graw Hill Lange; 2006.
15. Jr.Ligget WH, Forastiere AA. Chemotherapy for Head and Neck Cancer. In
al CCWe, editor. Otolaryngology-Head and Neck Surgery.; 1999. p. 124-126.
16.
Kentjono WA, Kemoterapi pada Tumor Ganas THT-Kepala Leher
Pendidikan
Kedokteran Berkelanjutan III Ilmu Penyakit Telinga Hidung
Tenggorok-Kepala Leher, SMF Ilmu Penyakit THT FK Unair/ RSUD dr.
Soetomo, Surabaya November 2002,108- 21
17. Suzuki RK, Hata M, Tateishi U, Taguchi T, Takano S, Minaswisawa MO, et
al. Defenitive chemo-radiotherapy for squamous cell carcinoma of the
pharynx:impact of baseline low hemoglobin level. The Japanese Society of
Nuclear Medicine.2014 September.
18. American Cancer Society. [Online].; 2015 [cited 2016 June 2. Available
from:
http://www.cancer.org/cancer/nasopharyngealcancer/detailedguide/nasophary
ngeal-cancer-signs-and-symptoms.
19
Head and Neck Pathology. Update on Nasopharyngeal Carcinoma. 2007
September p:81-86
20
HannaDams-Kozlowska , ElizaKwiatkowska-Borowczyk , Gryska K
Lewandowska A, Marszalek A, Sebastian A, et al. Effects of Designer
Hyper-Interleukin 11 (H11)on Hematopoiesisin Myelosuppressed Mice. The
National Science Center, Poland. 2016 April.
21
MurayK R, Granner k D, Roadwell w V. Biokimia Harper. 27th ed.
Wulandari N, Rendy L, Dwijayanthi L, Liena , Dany F, Rachman L, editors.
Jakarta: EGC; 2009.
22
Sherwood L. Fisiologi Manusia Pendit B, Santoso B, editors. Jakarta: EGC;
2009.
Universitas Sumatera Utara
38
23
Newman D. Kamus Kedokteran Dorland. 29th ed. Setiawan A, Bani A,
Widjaja Aea, editors. Jakarta: EGC; 2002.
24
Woo JK, Hasselt CA, Nasopharyngeal Carcinoma, in : Scott-Brown’s
Otorhinolaryngologi, Head And Neck Surgery, 7th edition, volume 2, Great
Britain,2008 ; p.2445-70.
25
Ondrey FG, Wright SK, Neoplasma of the Nasopharynx, in ; Ballanger’s
Manual of Otorhinolaryngology Head and neck Surgery,Hamilton, Ontario,
2003; p.484-95.
26
Chan et al, Nasopharyngeal Carcinoma, in : Pathology and Genetics of Head
and neck Tumours, WHO Classification of Tumours, Lyon, 2005,p.81-97.
23.
Universitas Sumatera Utara
DAFTAR PUSTAKA
1.
Indonesia KKR. Stop Kanker. Situasi Penyakit Kanker. 2015 Febuari: p. 7.
2.
Cao SM, Simons MJ, Qian aCN. The Prevalence and Prevention of
Nasopharyngeal Carcinoma in China. Chinese Journal of Cancer. 2011
january; 30(2).
3.
American Cancer Society. [Online].; 2015 [cited 2015 January 15. Available
from:
http://www.cancer.org/cancer/nasopharyngealcancer/detailedguide/nasophary
ngeal-cancer-what-is-nasopharyngeal-cancer
4.
International Agency of Research on Cancer. [Online].;2010 Available from:
http://www.iarc.fr/search.php?cx=009987501641899931167
5.
Richard S. Snell MD. Clinical Anatomy For Medical Students. 6th ed. et.al
HH, editor.: EGC; 2002.
6.
Nasional KPK. Panduan Praktisi Klinis Karsinoma Nasofaring: Kementrian
Kesehatan Republik Indonesia; 2008.
7.
Control UfIC. World Health Organization. [Online].; 2014 [cited 2016 April
23.
8.
Su O, Mao , Liang , Liu , al Je. American Cancer Society. [Online].; 2015
[cited 2016.
9.
Indonesia FKU. Buku Ajar Ilmu Kesehatan. In Prof.Dr.Efiaty Arsyad
Soepardi sTea, editor. Telinga Hidung Tenggorokan Kepala&Leher. Jakarta:
Fakultas Kedokteran Universitas Indonesia; 2007. p. 169.
10. Daniel T.T.Chua MBCB, Jonathan S.T.Sham MD, Damon T.k.Choy MBBS.
Prognostic Impact of Hemoglobin Levels on Treatment Outcome in Patients
with Nasopharyngeal Carcinoma Treated with Sequential Chemoradiotherapy
or Radiotherapy Alone. American Cancer Society. 2004 June; 101(2).
11. su Z, Mao YP, OuYang PY, Tang J, Lan Xw, Xie FY. Leucopenia and treatment
effiacy in advanced nasopharyngeal carcinoma. BioMedCentral Cancer. 2015.
Universitas Sumatera Utara
37
12. Mehta A, Hoffbrand V. At a Glance Hematologi. 2nd ed. Safitri A,
Astikawati R, editors.: copyright Erlangga; 2008.
13. Lichtman MAMD, Beutler EMD, Kipps TJMD,PD, et.al. Williams
Hematology. 7th ed. Abboud CN,MDea, editor.: The Mc.Graw-Hill
Companies; 2007.
14. Warren Levinson Md. Review of Medical Microbiology and Immunology.
9th ed. Malley J, Pancotti R, Davis K, editors. United Stage America: Mc
Graw Hill Lange; 2006.
15. Jr.Ligget WH, Forastiere AA. Chemotherapy for Head and Neck Cancer. In
al CCWe, editor. Otolaryngology-Head and Neck Surgery.; 1999. p. 124-126.
16.
Kentjono WA, Kemoterapi pada Tumor Ganas THT-Kepala Leher
Pendidikan
Kedokteran Berkelanjutan III Ilmu Penyakit Telinga Hidung
Tenggorok-Kepala Leher, SMF Ilmu Penyakit THT FK Unair/ RSUD dr.
Soetomo, Surabaya November 2002,108- 21
17. Suzuki RK, Hata M, Tateishi U, Taguchi T, Takano S, Minaswisawa MO, et
al. Defenitive chemo-radiotherapy for squamous cell carcinoma of the
pharynx:impact of baseline low hemoglobin level. The Japanese Society of
Nuclear Medicine.2014 September.
18. American Cancer Society. [Online].; 2015 [cited 2016 June 2. Available
from:
http://www.cancer.org/cancer/nasopharyngealcancer/detailedguide/nasophary
ngeal-cancer-signs-and-symptoms.
19
Head and Neck Pathology. Update on Nasopharyngeal Carcinoma. 2007
September p:81-86
20
HannaDams-Kozlowska , ElizaKwiatkowska-Borowczyk , Gryska K
Lewandowska A, Marszalek A, Sebastian A, et al. Effects of Designer
Hyper-Interleukin 11 (H11)on Hematopoiesisin Myelosuppressed Mice. The
National Science Center, Poland. 2016 April.
21
MurayK R, Granner k D, Roadwell w V. Biokimia Harper. 27th ed.
Wulandari N, Rendy L, Dwijayanthi L, Liena , Dany F, Rachman L, editors.
Jakarta: EGC; 2009.
22
Sherwood L. Fisiologi Manusia Pendit B, Santoso B, editors. Jakarta: EGC;
2009.
Universitas Sumatera Utara
38
23
Newman D. Kamus Kedokteran Dorland. 29th ed. Setiawan A, Bani A,
Widjaja Aea, editors. Jakarta: EGC; 2002.
24
Woo JK, Hasselt CA, Nasopharyngeal Carcinoma, in : Scott-Brown’s
Otorhinolaryngologi, Head And Neck Surgery, 7th edition, volume 2, Great
Britain,2008 ; p.2445-70.
25
Ondrey FG, Wright SK, Neoplasma of the Nasopharynx, in ; Ballanger’s
Manual of Otorhinolaryngology Head and neck Surgery,Hamilton, Ontario,
2003; p.484-95.
26
Chan et al, Nasopharyngeal Carcinoma, in : Pathology and Genetics of Head
and neck Tumours, WHO Classification of Tumours, Lyon, 2005,p.81-97.
23.
Universitas Sumatera Utara